Home › Funds › Champlain Investment Partners, LLC › CAI
Champlain Investment Partners, LLC position in CAI
CARIS LIFE SCIENCES INC · Health Care
Champlain Investment Partners, LLC reported holding 1,053,960 shares of CAI (CARIS LIFE SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$32.3M, representing 1.11% of its reported portfolio and ranking #21 among its reported holdings. Champlain Investment Partners, LLC has disclosed CAI holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Champlain Investment Partners, LLC's CAI position evolved
Champlain Investment Partners, LLC first disclosed a stake in CAI in Q4 2025 at 939,365 shares (US$25.3M). The position peaked in Q3 2026 at 1,053,960 shares, worth US$32.3M. Across 4 filings, Champlain Investment Partners, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,053,960 shares valued at US$32.3M. Notable position changes include a 29% increase in Q1 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 939.37K | $25.34M | New |
| Q1 2026 | 1.21M | $21.60M | Add |
| Q2 2026 | 1.05M | $18.69M | Reduce |
| Q3 2026 | 1.05M | $32.28M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CAI and 13F data
CAI (CARIS LIFE SCIENCES INC) is a Health Care company. 62 other funds we track also report a position in CAI — the largest reported positions include Coatue Management (US$175.0M), COATUE MANAGEMENT LLC (US$175.0M), BRAIDWELL LP (US$147.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CAI
- Coatue Management 9.82M sh · $174.99M · Q2 2026
- COATUE MANAGEMENT LLC 9.82M sh · $174.99M · Q2 2026
- BRAIDWELL LP 8.26M sh · $147.12M · Q2 2026
- PointState Capital LP 6.83M sh · $121.69M · Q2 2026
- Sixth Street Partners Management Company, L.P. 3.03M sh · $92.89M · Q3 2026
- J. H. Whitney Equity Partners VI, LLC 1.75M sh · $53.62M · Q3 2026
- ORBIMED ADVISORS LLC 2.81M sh · $50.02M · Q2 2026
- MAK CAPITAL ONE LLC 1.94M sh · $34.52M · Q2 2026
- Duquesne Family Office LLC 1.89M sh · $33.76M · Q2 2026
- ZEVENBERGEN CAPITAL INVESTMENTS LLC 719.60K sh · $22.04M · Q3 2026
- Pembroke Management, LTD 299.79K sh · $9.18M · Q3 2026
More on Champlain Investment Partners, LLC
FAQ
How long has Champlain Investment Partners, LLC held CAI?
Champlain Investment Partners, LLC has disclosed CAI holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Champlain Investment Partners, LLC's current position in CAI?
As of Q3 2026, Champlain Investment Partners, LLC holds 1.05M shares of CAI (CARIS LIFE SCIENCES INC), valued at $32.28M, representing 1.11% of its reported portfolio and ranking #21.
Has Champlain Investment Partners, LLC been buying or selling CAI?
In the latest 13F filing (Q3 2026), Champlain Investment Partners, LLC held unchanged its position in CAI. The position peaked in Q3 2026 at 1.05M shares.
Which other funds hold CAI?
Other major institutional holders of CAI include Coatue Management, COATUE MANAGEMENT LLC, BRAIDWELL LP, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.